| Ticker Details |
|
Gossamer Bio, Inc.
|
| IPO Date: |
February 4, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$49.31M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.24 | 3.70%
|
| Avg Daily Range (30 D): |
$0.02 | 5.81%
|
| Avg Daily Range (90 D): |
$0.05 | 6.01%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.91M |
| Avg Daily Volume (30 D): |
8.72M |
| Avg Daily Volume (90 D): |
13.3M |
| Trade Size |
| Avg Trade Size (Sh.): |
246 |
| Avg Trade Size (Sh.) (30 D): |
503 |
| Avg Trade Size (Sh.) (90 D): |
562 |
| Institutional Trades |
| Total Institutional Trades: |
1,350 |
| Avg Institutional Trade: |
$1.47M |
| Avg Institutional Trade (30 D): |
$2.75M |
| Avg Institutional Trade (90 D): |
$.93M |
| Avg Institutional Trade Volume: |
.29M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.7M |
| Avg Closing Trade (30 D): |
$3.37M |
| Avg Closing Trade (90 D): |
$.97M |
| Avg Closing Volume: |
355.76K |
|
|
| News |
May 25, 2026 @ 4:00 PM
Bronstein, Gewirtz & Grossman LLC Urges Gossamer B...
Source: Bronstein, Gewirtz & Grossman Llc
|
May 24, 2026 @ 11:25 PM
GOSSAMER DEADLINE: ROSEN, A LEADING INVESTOR RIGHT...
Source: Rosen Law Firm
|
May 21, 2026 @ 4:00 PM
Bronstein, Gewirtz & Grossman LLC Urges Gossamer B...
Source: Bronstein, Gewirtz & Grossman Llc
|
May 19, 2026 @ 7:58 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investo...
Source: Pomerantz Llp
|
May 19, 2026 @ 5:00 PM
Pulmonary Arterial Hypertension Clinical Trial Pip...
Source: Delveinsight
|
| Financials |
| |
TTM |
Q1 2026 |
Q3 2025 |
|
Basic EPS
|
|
$-.2
|
$-.21
|
|
Diluted EPS
|
|
$-.2
|
$-.21
|
|
Revenue
|
|
$16.96M
|
$13.29M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
|
$-46.66M
|
$-48.22M
|
|
Operating Income / Loss
|
|
$-44.87M
|
$-49.11M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
|
$3.4M
|
$-17.28M
|
|
PE Ratio
|
|
|
|
|
|
|
